Applied Biology, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: 1

Market Cap: -

Website: http://www.appliedbiology.com

Clinical Trials

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

Phase 3

Not yet recruiting

Conditions: Canities
Grey Hair

Interventions: Drug: CS-001
Drug: Placebo Topical Solution

First Posted Date: 2024-12-20

Last Posted Date: 2024-12-20

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 240

Registration Number: NCT06745336

Clinical Study of DA-001 As a Treatment for Telogen Effluvium

Phase 3

Not yet recruiting

Conditions: Telogen Effluvium

Interventions: Drug: DA-001
Other: Placebo
Drug: Phenylephrine
Other: Intact5

First Posted Date: 2024-10-18

Last Posted Date: 2024-12-19

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 480

Registration Number: NCT06648850

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Phase 3

Not yet recruiting

Conditions: Androgenetic Alopecia
Female Pattern Baldness
Male Pattern Baldness

Interventions: Dietary Supplement: DA-005
Drug: Topical minoxidil 5%
Drug: DA-002
Other: Placebo Topical Solution
Dietary Supplement: Placebo Oral Tablet

First Posted Date: 2024-07-15

Last Posted Date: 2024-12-19

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 516

Registration Number: NCT06501924

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Phase 3

Withdrawn

Conditions: Androgenetic Alopecia
Female Pattern Baldness

Interventions: Drug: Topical minoxidil 5%
Dietary Supplement: Daniel Alain Probiotic Treatment for Androgenetic Alopecia

First Posted Date: 2024-07-03

Last Posted Date: 2024-10-15

Lead Sponsor: Applied Biology, Inc.

Registration Number: NCT06484881

Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002

Not Applicable

Completed

Conditions: Hair Diseases
Alopecia
Hair Loss

Interventions: Combination Product: DA-OTC-002

First Posted Date: 2023-10-23

Last Posted Date: 2023-10-23

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 76

Registration Number: NCT06095739

Locations: 🇧🇷
Hospital Oscar Nicolau, Manaus, Brazil

Treatment for Post Acute COVID-19 Syndrome

Not Applicable

Conditions: Tinnitus, Subjective

Interventions: Drug: Pimozide 1 MG

First Posted Date: 2022-08-19

Last Posted Date: 2022-08-22

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 50

Registration Number: NCT05507372

Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

Phase 3

Withdrawn

Conditions: Atopic Dermatitis

Interventions: Other: JW-100
Drug: Eucrisa

First Posted Date: 2021-08-23

Last Posted Date: 2022-12-19

Lead Sponsor: Applied Biology, Inc.

Registration Number: NCT05016284

Locations: 🇧🇷
Centro Universitário Nilton Lins, Manaus, Amazonas, Brazil

HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients

Phase 3

Conditions: COVID-19 Respiratory Infection

Interventions: Drug: HC-1119
Drug: Placebo

First Posted Date: 2021-08-02

Last Posted Date: 2022-02-18

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 602

Registration Number: NCT04986176

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Phase 3

Withdrawn

Conditions: Covid19
SARS (Severe Acute Respiratory Syndrome)

Interventions: Drug: Placebo
Drug: Proxalutamide

First Posted Date: 2021-04-22

Last Posted Date: 2022-03-04

Lead Sponsor: Applied Biology, Inc.

Registration Number: NCT04853927

Locations: 🇧🇷
Samel Hospital, Manaus, Amazonas, Brazil

Proxalutamide Treatment for COVID-19 Female Outpatients

Phase 3

Withdrawn

Conditions: Covid19
SARS-CoV Infection

Interventions: Other: Standard of Care
Drug: Proxalutamide

First Posted Date: 2021-04-21

Last Posted Date: 2022-03-04

Lead Sponsor: Applied Biology, Inc.

Registration Number: NCT04853134

Locations: 🇧🇷
Corpometria Institute, Brasilia, Brazil

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy